ArticleVaccine2022

Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.

Murat SeyranPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.